Skip to main content
Signal8

Ryan Michael Lee

SEC insider (Form 3/4/5 filer). CIK 0001985918. Director at Coherus Oncology, Inc. (CHRS). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in REDWOOD CITY, CA.

Companies Ryan Michael Lee has filed insider reports for

  • Coherus Oncology, Inc. (CHRS): Director
Ryan Michael Lee profile photo

Ryan Michael Lee

CIK: 0001985918

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Coherus Oncology, Inc. logo
CHRS

Coherus Oncology, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Coherus Oncology, Inc. logo
    CHRS

    Coherus Oncology, Inc.

    Jun 5, 2026
    Award
    Direct
    30K shares-
  • Coherus Oncology, Inc. logo
    CHRS

    Coherus Oncology, Inc.

    Jun 12, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    112K shares-

1-2 of 2